Sign inGet started

Horobin Joanna

Insider CIK 1560959 · LQDA Director · VYNT Director · VSTM Chief Medical Officer · KYMR Director · LQDA Director · IDRA SVP and Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LQDA Liquidia Corp A Award2026-06-162026-06-185,882— $039,637SEC↗
LQDA Liquidia Corp S Sale2025-08-192025-08-215,000$27.17 $135.8K33,755SEC↗
LQDA Liquidia Corp A Award2025-06-172025-06-2018,396— $038,755SEC↗
LQDA Liquidia Corp A Award2024-06-202024-06-2420,359— $020,359SEC↗
KYMR Kymera Therapeutics, Inc. M Exercise deriv2024-06-072024-06-078,500— $033,195SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2024-06-072024-06-076,313$33.11 $209.0K0SEC↗
KYMR Kymera Therapeutics, Inc. M Exercise2024-06-072024-06-078,500$2.08 $17.7K8,500SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2024-06-072024-06-072,187$32.65 $71.4K6,313SEC↗
LQDA Liquidia Corp A Award deriv2023-06-192023-06-2120,000— $020,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2023-06-152023-06-2012,000— $012,000SEC↗
VYNT Vyant Bio, Inc. A Award2023-01-172023-01-197,526— $023,123SEC↗
VYNT Vyant Bio, Inc. A Award2022-10-172022-10-1914,285— $077,994SEC↗
VYNT Vyant Bio, Inc. A Award2022-07-182022-07-298,092— $063,709SEC↗
LQDA Liquidia Corp A Award deriv2022-06-172022-06-2220,000— $020,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2022-06-152022-06-1612,000— $012,000SEC↗
VYNT Vyant Bio, Inc. A Award2022-04-182022-04-196,796— $055,617SEC↗
VYNT Vyant Bio, Inc. A Award2022-03-302022-04-0143,478— $048,821SEC↗
VYNT Vyant Bio, Inc. A Award2022-01-182022-01-205,343$1.31 $7.0K5,343SEC↗
LQDA Liquidia Corp A Award deriv2021-08-202021-09-0120,000— $020,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2021-06-162021-06-1720,063— $020,063SEC↗
VYNT Vyant Bio, Inc. J Other deriv2021-03-302021-04-015,068— $05,068SEC↗
VYNT Vyant Bio, Inc. A Award deriv2021-03-302021-04-0113,015— $013,015SEC↗
LQDA Liquidia Corp A Award deriv2021-03-242021-03-2635,872— $035,872SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2020-08-202020-08-2140,127— $040,127SEC↗
LQDA Liquidia Technologies Inc A Award deriv2020-06-222020-06-2320,000— $020,000SEC↗
LQDA Liquidia Technologies Inc A Award deriv2019-09-112019-09-1215,000— $015,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award2019-01-032019-01-0718,100— $020,144SEC↗
IDRA IDERA PHARMACEUTICALS, INC P Buy2018-12-202018-12-20300$3.45 $1.0K2,044SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2017-01-032017-01-06185,000— $0185,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2015-11-302015-12-02275,000— $0275,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2015-11-302015-12-02325,000— $0325,000SEC↗
VSTM Verastem, Inc. A Award deriv2015-01-082015-01-12100,118— $0100,118SEC↗
VSTM Verastem, Inc. P Buy2014-12-292014-12-31750$8.60 $6.5K750SEC↗
VSTM Verastem, Inc. A Award deriv2014-01-072014-01-09100,000— $0100,000SEC↗
VSTM Verastem, Inc. A Award deriv2012-11-012012-11-02200,000— $0200,000SEC↗